Differential risk of herpes zoster infection with biologic agent use in rheumatoid arthritis: comment on the article by Yun et al

Publisher： John Wiley & Sons Inc

E-ISSN： 2151-4658|67|7|1041-1041

ISSN： 2151-464x

Source： ARTHRITIS CARE AND RESEARCH, Vol.67, Iss.7, 2015-07, pp. : 1041-1041

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lymphoma Risk in Japanese Patients With Rheumatoid Arthritis: Comment on the Article by Kameda et al

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 8, 2015-08 ,pp. : 1186-1186

John Wiley & Sons Inc

Access to resources Recommend Favorite

Methotrexate and Lung Disease in Rheumatoid Arthritis: Comment on the Article by Conway et al

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 9, 2014-09 ,pp. : 2641-2642

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk of Hospitalized Infection Among Rheumatoid Arthritis Patients Concurrently Treated With a Biologic Agent and Denosumab

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 6, 2015-06 ,pp. : 1456-1464

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risks of Herpes Zoster in Patients With Rheumatoid Arthritis According to Biologic Disease‐Modifying Therapy

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 5, 2015-05 ,pp. : 731-736

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is the Homeostatic Model Assessment of Insulin Resistance a Poor Predictor of Cardiovascular Disease in Rheumatoid Arthritis? Comment on the Article by Giles et al

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 9, 2015-09 ,pp. : 2548-2550

John Wiley & Sons Inc

Access to resources Recommend Favorite